The UK Biobank imaging enhancement of 100,000 participants: rationale, data collection, management and future directions
The UK Biobank imaging enhancement of 100,000 participants: rationale, data collection, management and future directions
UK Biobank is a population-based cohort of half a million participants aged 40–69 years recruited between 2006 and 2010. In 2014, UK Biobank started the world’s largest multi-modal imaging study, with the aim of re-inviting 100,000 participants to undergo brain, cardiac and abdominal magnetic resonance imaging, dual-energy X-ray absorptiometry and carotid ultrasound. The combination of large-scale multi-modal imaging with extensive phenotypic and genetic data offers an unprecedented resource for scientists to conduct health-related research. This article provides an in-depth overview of the imaging enhancement, including the data collected, how it is managed and processed, and future directions.
Littlejohns, Thomas J.
ea8614d6-9dcd-4a9f-adfc-16cdc7942ab3
Holliday, Jo
62ce4f67-0cbe-49f4-a4e9-3c72df17d5f1
Gibson, Lorna M.
eb0e5c31-21e3-419b-a97c-a7d063ec8780
Garratt, Steve
47585fbc-ff14-4efe-9154-e1e3a41a48f1
Oesingmann, Niels
e5b42af6-d017-4ccf-81ce-0a71e7285e43
Alfaro-Almagro, Fidel
966035bc-8627-4538-96de-2acef47e436c
Bell, Jimmy D.
7f913309-c2f4-42ba-bcfb-701cd0662e64
Boultwood, Chris
d1161e60-6c6c-45ff-a40c-d004be6a463e
Collins, Rory
b14930f1-0b85-4274-adf0-5a31448602c7
Conroy, Megan C
1d9b10c2-af31-4afa-8183-39778411ee98
Crabtree, Nicola
bfbfdc1e-b11f-4410-8a59-e3d15e5877dc
Doherty, Nicola
428b3f79-77e8-4d63-9b69-d61819114ebf
Frangi, Alejandro
35127be7-3586-4fff-a4a2-bb79cc228141
Harvey, Nicholas
ce487fb4-d360-4aac-9d17-9466d6cba145
Leeson, Paul
34dc217d-32e6-4c63-bcbb-334844939c92
Miller, Karla L.
550fd362-6bff-4d9a-a88e-89a2469bbdc3
Neubauer, Stefan
c8a34156-a4ed-4dfe-97cb-4f47627d927d
Petersen, Steffen E.
04f2ce88-790d-48dc-baac-cbe0946dd928
Sellors, Jonathan
3cd139fe-1049-412a-9277-6c18adfc45c4
Sheard, Simon
a4860b8e-6e57-4f45-8e09-e5cde62b26d6
Smith, Stephen M.
c04c3de9-6002-4571-862e-9a4ebc4904f4
Sudlow, Cathie LM
9f32df68-739b-4550-87c9-ac0db6ca7789
Matthews, Paul M.
8c37e5aa-c28d-46ea-ab4a-e947d36fedf7
Allen, Naomi E.
fa846c50-6ef7-4541-9294-12971e2e90b3
26 May 2020
Littlejohns, Thomas J.
ea8614d6-9dcd-4a9f-adfc-16cdc7942ab3
Holliday, Jo
62ce4f67-0cbe-49f4-a4e9-3c72df17d5f1
Gibson, Lorna M.
eb0e5c31-21e3-419b-a97c-a7d063ec8780
Garratt, Steve
47585fbc-ff14-4efe-9154-e1e3a41a48f1
Oesingmann, Niels
e5b42af6-d017-4ccf-81ce-0a71e7285e43
Alfaro-Almagro, Fidel
966035bc-8627-4538-96de-2acef47e436c
Bell, Jimmy D.
7f913309-c2f4-42ba-bcfb-701cd0662e64
Boultwood, Chris
d1161e60-6c6c-45ff-a40c-d004be6a463e
Collins, Rory
b14930f1-0b85-4274-adf0-5a31448602c7
Conroy, Megan C
1d9b10c2-af31-4afa-8183-39778411ee98
Crabtree, Nicola
bfbfdc1e-b11f-4410-8a59-e3d15e5877dc
Doherty, Nicola
428b3f79-77e8-4d63-9b69-d61819114ebf
Frangi, Alejandro
35127be7-3586-4fff-a4a2-bb79cc228141
Harvey, Nicholas
ce487fb4-d360-4aac-9d17-9466d6cba145
Leeson, Paul
34dc217d-32e6-4c63-bcbb-334844939c92
Miller, Karla L.
550fd362-6bff-4d9a-a88e-89a2469bbdc3
Neubauer, Stefan
c8a34156-a4ed-4dfe-97cb-4f47627d927d
Petersen, Steffen E.
04f2ce88-790d-48dc-baac-cbe0946dd928
Sellors, Jonathan
3cd139fe-1049-412a-9277-6c18adfc45c4
Sheard, Simon
a4860b8e-6e57-4f45-8e09-e5cde62b26d6
Smith, Stephen M.
c04c3de9-6002-4571-862e-9a4ebc4904f4
Sudlow, Cathie LM
9f32df68-739b-4550-87c9-ac0db6ca7789
Matthews, Paul M.
8c37e5aa-c28d-46ea-ab4a-e947d36fedf7
Allen, Naomi E.
fa846c50-6ef7-4541-9294-12971e2e90b3
Littlejohns, Thomas J., Holliday, Jo, Gibson, Lorna M., Garratt, Steve, Oesingmann, Niels, Alfaro-Almagro, Fidel, Bell, Jimmy D., Boultwood, Chris, Collins, Rory, Conroy, Megan C, Crabtree, Nicola, Doherty, Nicola, Frangi, Alejandro, Harvey, Nicholas, Leeson, Paul, Miller, Karla L., Neubauer, Stefan, Petersen, Steffen E., Sellors, Jonathan, Sheard, Simon, Smith, Stephen M., Sudlow, Cathie LM, Matthews, Paul M. and Allen, Naomi E.
(2020)
The UK Biobank imaging enhancement of 100,000 participants: rationale, data collection, management and future directions.
Nature Communications, 11 (1), [2624].
(doi:10.1038/s41467-020-15948-9).
Abstract
UK Biobank is a population-based cohort of half a million participants aged 40–69 years recruited between 2006 and 2010. In 2014, UK Biobank started the world’s largest multi-modal imaging study, with the aim of re-inviting 100,000 participants to undergo brain, cardiac and abdominal magnetic resonance imaging, dual-energy X-ray absorptiometry and carotid ultrasound. The combination of large-scale multi-modal imaging with extensive phenotypic and genetic data offers an unprecedented resource for scientists to conduct health-related research. This article provides an in-depth overview of the imaging enhancement, including the data collected, how it is managed and processed, and future directions.
Text
Revised manuscript
- Accepted Manuscript
Text
The UK Biobank imaging enhancemen
- Version of Record
More information
Accepted/In Press date: 3 April 2020
Published date: 26 May 2020
Additional Information:
Funding Information:
We would first like to acknowledge all UK Biobank participants for not only generously dedicating their free time to participate, but for also maintaining contact over many years that has made an imaging study of this scale possible. L.M.G. was funded by a Wellcome Trust Clinical Research Training Fellowship (107190/Z/15/Z). A.F.F. acknowledges past and ongoing contributions of Le Zhang, Rahman Attar, Dr Marco Pereañez, Mohsen Farzi, Dr Jose Maria Pozo, Milton Hoz and Prof. J Mark Wilkinson on setting up the CMR and DXA quality assessment and quantitative analysis pipelines within the UKB. He also acknowledges partial support from EPSRC (EP/N026993/1), the Royal Academy of Engineering Chair in Emerging Technology (CiET1819/19) and the European Commission (FP7-ICT-2011-9-601055,H2020-SC1-PM-16-2017-777119, H2020-SC1-PM-17-2017-777090). P.L. acknowledges support from the NIHR Oxford Biomedical Research Centre, Oxford BHF Centre for Research Excellence and EPSRC. P.M.M. acknowledges generous personal and research support from the Edmond J Safra Foundation and Lily Safra, an NIHR Senior Investigator Award, the UK Dementia Research Institute and the NIHR Biomedical Research Centre at Imperial College London”. S.E.P. acknowledges support from the National Institute for Health Research Barts Biomedical Research Centre. S.M.S. and K.L.M. are supported by Wellcome Trust. The brain image processing is carried out on compute clusters at the Oxford Biomedical Research Computing (BMRC) facility and FMRIB (part of the Wellcome Centre for Integrative Neuroimaging). BMRC is a joint development between the Wellcome Centre for Human Genetics and the Big Data Institute, supported by Health Data Research UK and the NIHR Oxford Biomedical Research Centre. We are grateful to Dr Eleni Kariki and the late Professor Judith Adams for their adjudication of DXA-related incidental findings, to Dr Neil Rane and formerly Dr Alan Jackson for adjudication of brain-related incidental findings, Dr Stephen Lee for adjudication of body-related incidental findings, and Dr Francesca Pugliese and formerly Dr Alexia Rossi and Dr Ermanno Capuano for adjudication of cardiac-related incidental findings. Christie’s Medical Physics provide MR safety support/advice as well as radiation protection advice. We would like to thank Mr Jonathan Price for his helpful comments on the custom-built PACS and Dr Mihir Sanghvi for his contributions to the cardiac MRI section. The following are current members of the UK Biobank Imaging Working Group; Paul Matthews, Tony Goldstone, Andrew Blamire, Steffen Petersen, Cathie Sudlow, Lorna Gibson, Alan Jackson, Naomi Allen, Rory Collins, Paul Leeson, Karla Miller, Stefan Neubauer, Stephen Smith, Nicholas Harvey, Jimmy Bell and E. Louise Thomas. The UK Biobank imaging project is funded by the Medical Research Council and the Wellcome Trust. The repeat imaging of 10,000 participants is funded by Dementias Platform UK.
Funding Information:
Nicholas C. Harvey acknowledges consultancy/grant support/honoraria from Alliance for Better Bone Health, AMGEN, UCB, Radius Health, MSD, Eli Lilly, Servier, Shire, Consilient Healthcare and Internis Pharma, outside the submitted work. Paul Leeson acknowledges grant support from Lantheus Medical Imaging and Fukuda, consultancy fees from Intelligent Ultrasound and is a non-executive director of Ultromics. Steffen E.
Publisher Copyright:
© 2020, The Author(s).
Identifiers
Local EPrints ID: 441561
URI: http://eprints.soton.ac.uk/id/eprint/441561
ISSN: 2041-1723
PURE UUID: f5cd9e05-9cfc-4e77-9f60-eeb3040a2150
Catalogue record
Date deposited: 18 Jun 2020 16:30
Last modified: 06 Jun 2024 01:42
Export record
Altmetrics
Contributors
Author:
Thomas J. Littlejohns
Author:
Jo Holliday
Author:
Lorna M. Gibson
Author:
Steve Garratt
Author:
Niels Oesingmann
Author:
Fidel Alfaro-Almagro
Author:
Jimmy D. Bell
Author:
Chris Boultwood
Author:
Rory Collins
Author:
Megan C Conroy
Author:
Nicola Crabtree
Author:
Nicola Doherty
Author:
Alejandro Frangi
Author:
Paul Leeson
Author:
Karla L. Miller
Author:
Stefan Neubauer
Author:
Steffen E. Petersen
Author:
Jonathan Sellors
Author:
Simon Sheard
Author:
Stephen M. Smith
Author:
Cathie LM Sudlow
Author:
Paul M. Matthews
Author:
Naomi E. Allen
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics